Market capitalization | $2.28b |
Enterprise Value | $24.26b |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 26.58 |
EV/Sales (TTM) EV/Sales | 2.64 |
P/S ratio (TTM) P/S ratio | 0.25 |
P/B ratio (TTM) P/B ratio | negative |
Revenue growth (TTM) Revenue growth | 10.20% |
Revenue (TTM) Revenue | $9.20b |
As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.
7 Analysts have issued a Bausch Health Companies Inc. forecast:
7 Analysts have issued a Bausch Health Companies Inc. forecast:
Jun '24 |
+/-
%
|
||
Revenue | 9,202 9,202 |
10%
10%
|
|
Gross Profit | 5,436 5,436 |
15%
15%
|
|
EBITDA | 2,985 2,985 |
9%
9%
|
EBIT (Operating Income) EBIT | 1,717 1,717 |
22%
22%
|
Net Profit | -471 -471 |
153%
153%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Manufactures and markets pharmaceutical products
Head office | Canada |
CEO | Thomas Appio |
Employees | 20,270 |
Founded | 1994 |
Website | www.bauschhealth.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.